Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
10.16
+0.41 (4.15%)
Market open: Aug 12, 2026, 3:35 PM EDT
9.31
-0.45 (-4.63%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
| Name | Position |
|---|---|
| Caitlin Webster CIPD, M.Sc. | Director of Talent Development |
| Dr. Carl L.G. Hansen Ph.D. | CEO, President & Chairperson |
| Dr. Veronique Lecault Ph.D. | CTO & Director |
| Marcie Thiessen CPA, CGA | Senior Director of Finance & Accounting |
| Mr. Andrew Booth M.B.A. | Chief Financial Officer |
| Mr. Andrew Knowles M.Sc. | Vice President of Operations |
| Mr. Martin Hogan M.Sc. | Senior Director of Strategic Finance & IR |
| Mr. Murray McCutcheon Ph.D. | Senior Vice President of Partnering |
| Mr. Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer |
| Ms. Tiffany Chiu B.Sc., Ph.D. | Vice President of Communications |
| Date | Type | Document |
|---|---|---|
| 2026-08-10 | 8-K | abcl-20260810.htm |
| 2026-08-07 | 8-K | abcl-20260807.htm |
| 2026-08-05 | 8-K | abcl-20260805.htm |
| 2026-08-05 | 10-Q | abcl-20260630.htm |
| 2026-07-29 | 8-K | abcl-20260729.htm |
| 2026-07-06 | 8-K | abcl-20260630.htm |
| 2026-06-17 | 8-K | abcl-20260617.htm |
| 2026-06-12 | 8-K | abcl-20260611.htm |
| 2026-06-05 | 8-K | abcl-20260601.htm |
| 2026-05-11 | 8-K | abcl-20260511.htm |